New Flu Vaccines May Take Some Of Fluvirin’s Market Share, Chiron Says
This article was originally published in The Pink Sheet Daily
Executive Summary
New flu vaccine manufacturers could take some of Chiron's market share following the company's inability to supply Fluvirin this season, Chiron said in a Securities & Exchange Commission filing Dec. 20